Medicare Part D coverage · morphine sulfate · RxCUI 892345
morphine sulfate 30 MG Extended Release Oral Capsule
Per the CMS 2026 Part D formulary file, morphine sulfate 30 MG Extended Release Oral Capsule is covered by 81 Medicare Part D plans (1.6% of enrollable products), averaging Tier 2.6, with prior authorization required on 0% of covering formularies.
- 1.6%
- Plan coverage
- 81
- Plans covering
- T2.6
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for morphine sulfate 30 MG Extended Release Oral Capsule
Per the CMS 2026 Part D formulary file, morphine sulfate 30 MG Extended Release Oral Capsule (RxNorm concept RXCUI 892345, generic name morphine sulfate) appears on 17 distinct formulary files spanning 81 Medicare Part D plan offerings - 1.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.6.
Real-world access to morphine sulfate 30 MG Extended Release Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 35.3% require step therapy. 70.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 255,247 Part D beneficiaries filled morphine sulfate 30 MG Extended Release Oral Capsule in 2023, with total plan-and-beneficiary spending of $66,058,479 and an average per-beneficiary annual cost of $258.80. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry morphine sulfate 30 MG Extended Release Oral Capsule today.
Coverage Details
- Formularies covering
- 17
- Plans covering
- 81
- Coverage rate
- 1.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 35.3% of formularies
- Quantity limits
- 70.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 255,247
- Total spending
- $66,058,479
- Avg per beneficiary
- $258.80
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering morphine sulfate 30 MG Extended Release Oral Capsule
81 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | No | $0 | CA |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | No | $8.90 | AR |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | No | $31.40 | OH |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | No | $32.70 | WV |
| Abilis Health (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $35.90 | KY, TN |
| CommuniCare Advantage ISNP (HMO I-SNP) | OH CHS SNP Inc. | T1 | No | $38.40 | IN, MD, OH |
| MMM Supremo (HMO C-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Diamante Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Unico (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Elite (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Deluxe (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Dorado Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| PMC Premier Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| PMC Max (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Plenitud (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Valioso (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
Show the next 30 plans
| MMM Combo Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Flexi Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Grandioso (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Mega Flex (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Relax Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Balance (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| Network Health Select (PPO) | Network Health Insurance Corporation | T3 | No | $0 | WI |
| Network Health Go (PPO) | Network Health Insurance Corporation | T3 | No | $0 | WI |
| Network Health Anywhere (PPO) | Network Health Insurance Corporation | T3 | No | $0 | WI |
| Network Health Choice (PPO) | Network Health Insurance Corporation | T3 | No | $0 | WI |
| Network Health Zero (PPO) | Network Health Insurance Corporation | T3 | No | $0 | WI |
| Network Health Cares (PPO D-SNP) | Network Health Insurance Corporation | T3 | No | $21.10 | WI |
| Network Health PlusRx (PPO) | Network Health Insurance Corporation | T3 | No | $38.60 | WI |
| Network Health PremierRx (PPO) | Network Health Insurance Corporation | T3 | No | $92.80 | WI |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| Geisinger Gold Preferred Complete Rx (PPO) | Geisinger Indemnity Insurance Company | T4 | No | $0 | PA |
| Geisinger Gold Secure Rx (HMO D-SNP) | Geisinger Health Plan | T4 | No | $0 | PA |
| Geisinger Gold Classic 360 Rx (HMO) | Geisinger Health Plan | T4 | No | $0 | PA |
| Geisinger Gold Classic Essential Rx (HMO) | Geisinger Health Plan | T4 | No | $0 | PA |
| Health New England Medicare Compass (PPO) | Health NEW England, Inc. | T4 | No | $0 | MA |
| Health New England Medicare Value (HMO) | Health NEW England, Inc. | T4 | No | $0 | MA |
| CDPHP $0 Medicare Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | No | $0 | NY |
| PacificSource Medicare Essentials Rx 27 (HMO) | Pacificsource Community Health Plans | T4 | No | $0 | OR |
Showing top 50 of 81 plans.
Frequently Asked Questions
Is morphine sulfate 30 MG Extended Release Oral Capsule covered by Medicare Part D?
Yes, morphine sulfate 30 MG Extended Release Oral Capsule is covered by 81 Medicare Part D plans (1.6% of all Part D formularies).
What tier is morphine sulfate 30 MG Extended Release Oral Capsule on Medicare Part D plans?
morphine sulfate 30 MG Extended Release Oral Capsule averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does morphine sulfate 30 MG Extended Release Oral Capsule require prior authorization?
0% of Part D formularies require prior authorization for morphine sulfate 30 MG Extended Release Oral Capsule. Step therapy: 35.3%. Quantity limits: 70.6%.
How much does Medicare spend on morphine sulfate 30 MG Extended Release Oral Capsule?
In 2023, total Medicare Part D spending on morphine sulfate 30 MG Extended Release Oral Capsule was $66,058,479, covering 255,247 beneficiaries. The average spend per beneficiary was $258.80.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 500 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection T2.6
- amoxapine 100 MG Oral Tablet T2.6
- fluorouracil 50 MG/ML Topical Cream T2.6
- 1000 ML glucose 100 MG/ML / sodium chloride 4.5 MG/ML Injection T2.6
- hydrochlorothiazide 12.5 MG / quinapril 10 MG Oral Tablet T2.6
- desonide 0.0005 MG/MG Topical Ointment T2.6
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA